Cardiovascular Diabetology

official impact factor 2.72

Open Access Highly Access Email this article to a friend

The need for a large-scale trial of fibrate therapy in diabetes: the rationale and design of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. [ISRCTN64783481]

The FIELD Study Investigators

Cardiovascular Diabetology 2004, 3:9 doi:10.1186/1475-2840-3-9

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.